CD8A and neoplasm: We observed a significant decrease in the C3 subtypes of multiple anti-tumor immune cells, including activated CD8 T cells, effector memory CD4 T cells, effector memory CD8 T cells, type 1 T helper cells, and type 17 T helper cells.